Home
Market Capitalization of Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM
Market Cap
Key Highlights
- The Market Cap of Jagsonpal Pharmaceuticals Ltd is ₹ 1456 crore as of 21 Feb 25 .
- The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 219.45 as of 21 Feb 15:30 .
- The dividend payouts of Jagsonpal Pharmaceuticals Ltd changed from ₹ 0.25 to ₹ 5 over 6 quarters. This represents a CAGR of 636.81% .

Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM
Share Price
Market Price of Jagsonpal Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 219.45 |
20 Feb 2025 | 218.7 |
19 Feb 2025 | 214.15 |
18 Feb 2025 | 215.8 |
17 Feb 2025 | 220.85 |
14 Feb 2025 | 229.95 |
13 Feb 2025 | 229.25 |
12 Feb 2025 | 241.05 |
11 Feb 2025 | 220.3 |
10 Feb 2025 | 241.8 |
SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd
BlinkX Score for Jagsonpal Pharmaceuticals Ltd
Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Jagsonpal Pharmaceuticals Ltd
Historical P/E Ratio of Jagsonpal Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Jagsonpal Pharmaceuticals Ltd
Historical Revenue of Jagsonpal Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Jagsonpal Pharmaceuticals Ltd
Historical EBITDA of Jagsonpal Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Jagsonpal Pharmaceuticals Ltd
Historical Net Profit of Jagsonpal Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Jagsonpal Pharmaceuticals Ltd
Historical Dividend Payouts of Jagsonpal Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Jagsonpal Pharmaceuticals Ltd
About Jagsonpal Pharmaceuticals Ltd
- Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
- The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
- Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
- It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
- In 1994, the company has also promoted Aresco Financial Services, a new financial company.
Jagsonpal Pharmaceuticals Ltd News Hub
Jagsonpal Pharmaceuticals AGM scheduled
Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the company will b
Read more
13 Aug 24
Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter
Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2
Read more
08 Aug 24
Jagsonpal Pharmaceuticals declare Quarterly Result
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2
Read more
01 Aug 24
Jagsonpal Pharmaceuticals to table results
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 October
Read more
17 Oct 24